be visible on the BioBusiness market ISSN 2300-0228

Log in | Register

Pivotal announces participation in two clinical trials with a novel investigational immunotherapy drug to treat melanoma and lung cancer
Impressions from the visit to Wageningen, the specter of famine, CRISPR Cas9 to the rescue!
Reach out to potential partners and customers in the Danish-Swedish life science cluster, Medicon Valley
Central European Healthcare Expo (20-21.05.2020 Global Expo Warsaw)
The world of healthcare ...

All articles

Filters:

Tag: biosimilars

Show search box

2014-06-25

Central and Eastern Europe region for execution of bio-similar and bio-equivalent studies.

Central and Eastern Europe region for execution of bio-similar and bio-equivalent studies.

The Central and Eastern Europe (CEE) region has recently become a rapidly developing sector for life sciences. During this year BioForum meeting two representatives of KCR, European Clinical Research Organization (CRO) have presented a panel session „Advantages of execution of biosimilar and bioequi... Read more

Tags bioforum , biosimilars , bioequivalent drugs , biological drugs

2013-12-24

Sandoz begins Phase III clinical trial for biosimilar adalimumab

Sandoz begins Phase III clinical trial for biosimilar adalimumab

Sandoz, the global leader in biosimilars, announced it has initiated a Phase III clinical trial with its biosimilar version of adalimumab (AbbVie’s HUMIRA®) – the leading treatment of several autoimmune conditions including rheumatoid arthritis, psoriasis, and Crohn’s disease. ... Read more

Tags biosimilars , clinical trials , Sandoz , adalimumab